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Abstract
Background: Ventriculoperitoneal (VP) shunt insertion remains the mainstay of 
treatment for hydrocephalus despite a high rate of complications. The predictors of 
shunt malfunction have been studied mostly in pediatric patients. In this study, we 
report our 11‑year experience with VP shunts in adult patients with hydrocephalus. 
We also assess the various factors affecting shunt survival in a developing country 
setting.
Methods: A retrospective chart analysis was conducted for all adult patients who 
had undergone shunt placement between the years 2001 and 2011. Kaplan–Meier 
curves were used to determine the duration from shunt placement to first malfunction 
and log‑rank (Cox–Mantel) tests were used to determine the factors affecting shunt 
survival.
Results: A total of 227 patients aged 18–85 years (mean: 45.8 years) were 
included in the study. The top four etiologies of hydrocephalus included 
post‑cranial surgery (23.3%), brain tumor or cyst (22.9%), normal pressure 
hydrocephalus (15%), and intracranial hemorrhage (13.7%). The overall incidence 
of shunt malfunction was 15.4% with the median time to first shunt failure being 
120 days. Etiology of hydrocephalus (P = 0.030) had a significant association with 
the development of shunt malfunction. Early shunt failure was associated with 
age (P < 0.001), duration of hospital stay (P < 0.001), Glasgow Coma Scale (GCS) 
score less than 13 (P = 0.010), excision of brain tumors (P = 0.008), and placement 
of extra‑ventricular drains (P = 0.033).
Conclusions: Patients with increased age, prolonged hospital stay, GCS score 
of less than 13, extra‑ventricular drains in situ, or excision of brain tumors were 
more likely to experience early shunt malfunction.
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INTRODUCTION
Ventriculoperitoneal (VP) shunt placement is the 
mainstay of treatment for hydrocephalus in both adult 
and pediatric patients.[2,5,28,33,43] In the United States alone, 
more than 30,000 procedures to relieve hydrocephalus are 
performed every year.[4,24] Despite this fact, VP shunting 
remains vulnerable to a number of complications. The 
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1‑year failure rate for VP shunts had been reported at 
around 40‑50% for pediatric patients and 29% for adults 
until a few decades ago.[5,6,18,40] More recent studies report 
a relatively lower rate of shunt failure, though it still 
remains substantial.[15,32,33,38,42]
VP shunt malfunction remains the most frequent reason 
for shunt revisions.[5,6,26,27,38] Although shunt failure 
has been studied extensively, most of the studies have 
addressed pediatric patients, and very little has been 
published on adult patients.[6,14,20,34,42] Moreover, many 
of these studies are from developed countries, which 
theoretically have only limited application to developing 
countries by virtue of the difference in etiologies.[9,16,41]
Hereby, we report an 11‑year experience of managing 
adult hydrocephalus, including etiologies of disease, 
patient demographics, shunt survival and failure rate, and 
causes of shunt malfunction.
MATERIALS AND METHODS
We performed a retrospective chart review using our 
inpatient database. Files were retrieved using International 
Classification of Diseases, 9th Revision‑Clinical 
Modification (ICD‑9‑CM) codes for “hydrocephalus” and 
“ventriculoperitoneal shunt.” Adult patients were defined 
as those who were 18 years of age or older. Each file was 
individually reviewed for various details such as patient 
demographics, presentation, neurological examination, 
laboratory and radiological investigations, medical and 
surgical management, hospital stay, follow‑up, and 
further management. Follow‑up in neurosurgery clinics 
was specifically reviewed for periodic shunt assessment, 
persistent or new onset symptoms, and any neurological 
deficits in terms of visual symptoms and motor and 
cognitive deficits. In case of shunt malfunction, cause 
and delay from first insertion to revision were also 
studied. Any and all further hospital admissions and 
surgeries were also studied.
Types of hydrocephalus we identified included 
normal pressure hydrocephalus (NPH), obstructive 
hydrocephalus, idiopathic hydrocephalus (etiology 
unknown), and communicating hydrocephalus, as 
previously reported by Reddy et al.[33] NPH at our center 
was diagnosed through a standard protocol involving gait 
and memory assessment pre‑ and post‑diagnostic lumbar 
drainage. This assessment involved the consultation 
of a neurologist as well as a physical therapist. 
Communicating hydrocephalus was the diagnosis 
reserved for high‑pressure hydrocephalus without an 
obvious obstructive pathology involving the ventricular 
system, although there might have been impairment in 
cerebrospinal fluid (CSF) absorption. Etiologies were 
grouped into different categories, which was slightly 
modified from Reddy et al.[33] and Mori et al.,[22] and 
included NPH, infectious or post‑infectious (bacterial 
meningitis or abscess, and tuberculous meningitis), 
infarcts, brain tumor/colloid and other types of 
cysts, subarachnoid hemorrhage (SAH), post‑cranial 
surgery, aneurysm or vascular malformation, and 
intracranial hemorrhage (other than SAH, but including 
intraventricular and intracerebral hemorrhages).[22,29,33] 
Post‑cranial surgery hydrocephalus is a unique subset 
of hydrocephalus that develops in patients following 
a cranial surgery.[10,21,39] It is believed to result from 
a combination of iatrogenic damage that occurred 
during the surgical procedure to the cells of the 
choroid plexus[11,21] and the alterations occurring 
postoperatively in the CSF circulation, cerebral blood 
flow auto‑regulation, and cerebral compliance.[39] Other 
etiologies included shunt malfunction (infection or 
blockage) presenting to us with known or unknown 
etiology, idiopathic, Arnold–Chiari or Dandy–Walker 
malformations, and traumatic brain injury (TBI).
The primary outcome of interest of this retrospective 
clinical study was shunt survival and revision rate. Causes 
of shunt failure were also determined. Shunt failure 
was defined as by Reddy et al.[33] and categorized as 
shunt infection, blockage and migration, CSF ascites, 
or shunt failure caused by an unknown factor. All these 
shunt complications led to shunt revision.
Data were recorded on a pre‑tested proforma. Statistical 
procedures included frequency determination, mean 
and standard deviation, and Pearson’s Chi‑square test 
for comparison of proportions. The Student’s t‑test 
and independent sample t‑test or the Mann–Whitney 
U test was used for comparison of means or medians, 
respectively. For all comparisons, a P < 0.05 was considered 
statistically significant. Kaplan–Meier curves were used 
to determine duration from shunt placement to first 
malfunction. The log‑rank (Mantel–Cox) test was used to 
determine the factors affecting shunt survival. Data entry 
and statistical analysis were performed on Statistical Package 
for Social Sciences version 19 (IBM SPSS  Statistics 19, 
IBM Corporation, Chicago, Illinois).
RESULTS
Patient demographics
A total of 319 patients underwent VP shunt placement 
during the 11‑year period. The total number of all types of 
neurosurgical procedures carried out at our center during 
the same time period was approximately 13,000. These 
VP shunt procedures were performed by seven different 
neurosurgeons. Pressure‑controlled shunts (Medtronic) 
were used in all cases at a medium pressure in most 
cases; these shunts have a distal valve located within the 
pump and cost about US $240 in Pakistan.
Out of the 319 patients identified initially, 92 were 
excluded because of the unavailability of medical 
records [Figure 1]. The mean age of patients 
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included in our study was 45.8 years, ranging from a 
minimum of 18 years to a maximum of 85 years. One 
hundred and fifty‑one (66.5%) patients were male, 
and hypertension (n = 161, 70.9%) and diabetes 
mellitus (n = 30, 13.2%) were the most common 
co‑morbid conditions [Table 1].
Etiologies and clinical manifestations
The etiologies of hydrocephalus in our patients 
included post‑cranial surgery (n = 53, 23.3%), 
brain tumor or cyst (n = 52, 22.9%), NPH (n = 34, 
15%), hemorrhage (n = 31, 13.7%), tuberculous 
meningitis (n = 9, 4.0%), bacterial meningitis or brain 
abscess (n = 2, 0.9%), and others (n = 46, 20.3%). Other 
etiologies included shunt malfunction (n = 16, 7%), 
TBI (n = 13, 5.7%), post‑meningitis (n = 14, 6.2%), 
Arnold–Chiari or Dandy–Walker malformation (n = 8, 
3.5%), and idiopathic (n = 7, 3.1%), as given in Table 2. 
Some patients had more than one etiology contributing 
to the development of hydrocephalus. Furthermore, all 
the patients who presented with shunt malfunction as 
etiology had undergone VP shunt placement in the past 
outside our center.
Of the 31 (13.7%) patients with intracranial hemorrhage 
as an etiology, 23 (10.1%) had SAH, 6 (2.6%) had 
intraparenchymal hemorrhage, and 2 (0.9%) had 
subdural hematoma. Among patients with brain 
tumors (n = 52, 22.9%), extra‑axial tumors (n = 30, 
13.2%) were more common than intra‑axial tumors 
(n = 22, 9.7%). Meningioma or oligodendroglioma 
(n = 12, 5.3%), vestibular schwannoma (n = 10, 4.4%), 
and hemangioblastoma or hemangioma (n = 7, 3.1%) 
were the most common. Posterior cranial fossa (n = 16, 
Adult Hydrocephalus Patients with
Ventriculoperitoneal Shunts
(n = 319)
Excluded
(n = 92)
Patients included in the final analysis
(n = 227)
 Etiology
Post-Cranial Surgery
Brain Tumor or cyst
NPH
Hemorrhage
Meningitis
Others
 Type
Obstructive
Normal Pressure
Communicatin
Idiopathic
Shunt Malfunction
(n = 35)
Ventriculoperitoneal
shunts Revisions
(n = 27)
Revision within 6 months
(n = 19)
Revision after 6 months
(n = 8)
53
52
34
31
11
46
155
39
25
8
Shunt blockade
Shunt Infection
Shunt migration
CSF Ascites
(Some patients had more than one
type of shut malfunction) 
25
 7
 3
 2
Figure 1: Illustrating the inclusion and exclusion of patient records 
for analysis in this study and a summary of the various etiologies 
and types of hydrocephalus with subsequent ventriculoperitoneal 
shunt procedures. NPH: Normal pressure hydrocephalus
Table 1: Demographics (N=227)
Characteristics n (%)
Sex
Male 151 (66.5)
Female 76 (33.5)
Age (>17 years)
Mean age 45.8±1.1 years
Young (18-40 years) 90 (39.6)
Middle-aged (40-65 years) 89 (39.2)
Elderly (>65 years) 48 (21.1)
Co-morbidities
Hypertension 161 (70.9)
Diabetes mellitus 30 (13.2)
Ischemic heart disease 7 (3.1)
Table 2: Etiologies of hydrocephalus with 
malfunction (P<0.05)
Etiology Patients 
(N=227)* 
(%)
Patients with 
shunt malfunction 
(n=35) (%)
Post-cranial surgery 53 (23.3) 7 (13.21)
Brain tumor 52 (22.9) 9 (17.31)
Normal pressure hydrocephalus 34 (15.0) 3 (8.82)
Hemorrhage 31 (13.7) 1 (3.23)
Shunt malfunction† 16 (7) 2 (12.50)
Post-meningitis hydrocephalus 14 (6.2) 3 (21.43)
Traumatic brain injury 13 (5.7) 2 (15.38)
Tuberculous meningitis 9 (4.0) 2 (22.22)
Arnold-Chiari/Dandy-Walker 
malformation
8 (3.5) 4 (50.00)
Idiopathic 7 (3.1) 1 (14.28)
Bacterial meningitis 2 (0.9) 0 (0)
Infarction or stroke 1 (0.4) 1 (100)
*Some patients had more than one etiology of hydrocephalus, †These patients had 
undergone ventriculoperitoneal shunt placement in the past outside our center and 
presented to us with shunt malfunction
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7.0%), cerebellopontine angle (n = 15, 6.6%) and supra‑ or 
parasellar (n = 9, 4.0%) region were the most common sites 
for tumors. The types of hydrocephalus were obstructive 
hydrocephalus (n = 155, 68.3%), NPH (n = 39, 17.2%), 
communicating hydrocephalus (n = 25, 11.0%), and 
idiopathic (n = 8, 3.5%) [Table 3]. Among patients with 
brain tumors (n = 52, 22.9%), most (n = 50, 22.0%) 
had obstructive hydrocephalus, while only two (3.9%) 
had communicating hydrocephalus secondary to choroid 
plexus papillomata. The relevant past medical and 
surgical history of our study subjects is summarized in 
Table 4.
Symptoms at the time of presentation included 
headache (n = 101, 44.5%), drowsiness or 
altered consciousness (n = 91, 40.1%), gait 
disturbances (n = 89, 39.2%), nausea or 
vomiting (n = 69, 30.4%), weakness (n = 52, 22.9%), 
urinary or fecal incontinence (n = 44, 19.4%), decline 
in memory (n = 26, 11.4%), visual abnormality (n = 26, 
11.4%), fever (n = 25, 11.0%), and seizures (n = 22, 
9.7%). On presentation, the Glasgow Coma Scale (GCS) 
score of patients ranged from 3 to 15, with a mean of 12 
and a median of 14. Twenty‑six (11.4%) patients were 
comatose  (GCS  ≤  8)  on  presentation,  while  GCS  score 
was less than 13 in all patients with drowsiness (n = 91, 
40.1%). Motor deficits were found in 99 (43.6%) patients. 
Laboratory investigations in these patients included serum 
chemistry, blood counts, blood culture, and radiological 
investigations. Lumbar puncture was performed in 
116 (51.1%) patients.
Management
Depending on the clinical condition of patients, they were 
managed in general ward, special care units, or intensive 
care units. The mean duration of hospital stay was 
13.6 ± 1.1 days. One hundred and ninety‑five (85.9%) 
of the patients received antibiotics. Mannitol was 
administered to 28 (12.3%) patients, while only 9 (4.0%) 
patients received acetazolamide. Anticonvulsants 
and steroids were used in 57 (25.1%) and 51 (22.5%) 
patients, respectively. Nine (4.0%) patients also received 
anti‑tuberculous therapy.
Surgical management of the patients other than VP shunt 
placement included extra‑ventricular drains (n = 43, 
18.9%), craniotomy or craniectomy (n = 31, 
13.7%), clipping of aneurysm (n = 12, 5.3%), 
ventriculostomy (n = 5, 2.2%) and other procedures. All 
the patients included in this study underwent VP shunt 
placement. Two hundred (88.1%) patients underwent VP 
shunt placement only once, while 27 (11.9%) patients 
required revision of the malfunctioned shunt later 
on. Of these patients, four (1.8%) required revision of 
the malfunctioned shunt during the same admission. 
A right‑sided shunt was placed in 209 (92.1%) patients, 
while the remaining 18 (7.9%) patients received a 
left‑sided shunt.
Clinical follow‑up
Only 161 (70.9%) patients followed up regularly; rest of 
the patients (n = 66, 29.1%) were lost to follow‑up after 
the first postoperative clinic visit. The mean duration of 
follow‑up was 321.6 days. Twelve (5.3%) patients died, 
most of whom (n = 10, 4.4%) died within a month 
after surgery. The remaining two patients (0.9%) died 
2 months and 10 months post‑surgery, respectively. 
Cardiac arrest (n = 3, 1.3%), brain‑stem death (n = 2, 
0.9%), and pulmonary embolism (n = 1, 0.4%) were the 
known causes of death in these patients. The exact cause 
of death in the remaining cases was not known.
Shunt complications
The incidence of overall shunt malfunction was found 
to be 15.4%, while the incidence of shunt revision was 
14.1%. Kaplan–Meier curve showed that shunt failure 
rates at 6 months, 1 year, and 6 years were 19/227 (8.4%), 
25/227 (11.0%), and 35/227 (15.4%), respectively. The 
most common causes of shunt malfunction were shunt 
blockade (n = 25, 11.0%), shunt infection (n = 8, 3.5%), 
shunt migration (n = 2, 0.9%), and CSF ascites (n = 2, 
0.9%) [Table 5]. Of the 35 patients who experienced 
shunt malfunction, two patients suffered both shunt 
blockage and shunt infection. The development of shunt 
malfunction was significantly influenced by the principal 
etiology of the hydrocephalus (P = 0.030). Of 74 patients 
with brain tumors – some of which were post‑excision and 
the rest were diagnosed during admission – 10 patients 
had shunt malfunction (P = 0.580). Nine of these patients 
Table 3: Types of hydrocephalus with malfunction (P=0.726)
Type of hydrocephalus 
(N=227)
n (%) Patients with shunt 
malfunction (n=35)
Obstructive hydrocephalus 155 (68.3) 25 (16.13)
Normal pressure hydrocephalus 39 (17.2) 4 (10.26)
Communicating hydrocephalus 25 (11.0) 5 (20.00)
Idiopathic 8 (3.5) 1 (12.50)
Table 4: Past medical and surgical history of study 
subjects (N=227)
n %
Past history
Mass lesion 47 20.7
Meningitis 25 11.0
Hydrocephalus 24 10.6
Head injury 15 6.6
Subarachnoid hemorrhage 14 6.2
Types of interventions
Surgery for mass lesion 53 23.3
Ventriculoperitoneal shunt placement 24 10.6
Received antibiotics for meningitis 19 8.4
Anti-tuberculous drugs 17 7.5
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underwent shunt revision. Out of 53 post‑cranial surgery 
patients, only 7 developed shunt malfunction (P = 0.611) 
and all of them had shunt revision. Of 34 patients with 
NPH, 3 developed shunt malfunction (P = 0.248); 
shunt revision was performed in all of them. Amongst 
31 patients with hemorrhage, only 1 patient had shunt 
malfunction and required shunt revision (P = 0.043). 
Shunt malfunction was not found to have a significant 
impact on the overall functional outcome of 
patients (P = 0.364) [Table 6]. Among elderly patients, 
causes of shunt failure included shunt blockage (n = 2), 
shunt migration (n = 2), and shunt infection (n = 1).
Factors affecting time to first shunt failure (VP 
shunt survival)
Overall median time from shunt placement to 
shunt malfunction was 120 days, ranging from 2 to 
2095 days [Figure 2]. Kaplan–Meier plot showed that 
the median time from shunt placement to first shunt 
failure was significantly different among all individuals in 
principal etiologies (P = 0.003, log‑rank test) [Figure 3]. 
Individuals with intracranial hemorrhage, brain tumor, 
post‑cranial surgery, and NPH showed a shortest shunt 
survival to first shunt failure. Median time to VP shunt 
failure did not differ significantly between the different 
types of hydrocephalus (P = 0.174, log‑rank test). Patients’ 
gender did not show significant statistical difference 
in median time from shunt placement to first shunt 
failure between male and female individuals (P = 0.671, 
log‑rank test) or medical co‑morbidities (P = 0.701, 
log‑rank test). Time to first shunt failure for elderly 
patients was significantly lower than that for other 
patients (P < 0.001, log‑rank test), ranging between 4 
and 120 days. Duration of hospital stay was statistically 
significant for median time to shunt failure (P < 0.001, 
log‑rank test). Difference in median time from shunt 
Table 6: Factors affecting shunt malfunction (N=227)
Factors P* Factors P*
Demographics Management
Sex 0.503 Hospital care unit 0.601
Age 0.298 Duration of hospital stay 0.249
Comorbid 
conditions
0.229 Antibiotics given 0.470
Past medical and 
surgical history
Mannitol 0.067
Meningitis 0.193 Diamox 0.802
Hydrocephalus 0.356 Steroids 0.962
Head injury 0.822 Anticonvulsants 0.391
Stroke/SAH 0.997 Anti-tuberculosis drugs 0.283
Mass lesion 0.810 Surgical intervention 0.994
Antibiotics 0.133 Type of surgical intervention 0.001
Anti-tuberculosis 
drugs
0.137 Extra-ventricular drain 0.445
VP shunt 0.160 Side of VP shunt placement 0.507
Surgical repair 0.665 Number of revisions <0.001
KPS 0.364
SAH: Subarachnoid hemorrhage, VP: Ventriculoperitoneal, KPS: Karnofsky performance 
score, *P value for qualitative and quantitative variables based on Pearson 
Chi‑square (χ2) test and Mann‑Whitney U test, respectively
Factors having a statistically significant association with shunt malfunction are shown 
in bold.
Table 5: Complications of ventriculoperitoneal shunt*
Complication type n (%)
Shunt blockage 25 (11)
Shunt infection 7 (3.5)
Shunt migration 3 (1.3)
Shunt CSF ascites 2 (0.9)
CSF: Cerebrospinal fluid, *Two patients experienced both shunt blockage and shunt 
infection
Figure 2: Kaplan–Meier shunt survival analysis for adult hydrocephalus 
shows overall median time to first shunt failure was 120 days. 
Shunt survival time ranged from 0 to 2095 days. Out of 35 shunt 
malfunctions, 30 occurred before 500 days
Figure 3: Kaplan–Meier shunt survival analysis for adult hydrocephalus 
shows that etiologies of hydrocephalus significantly differed in median 
time to first shunt failure (P = 0.003, log-rank test). NPH: Normal 
pressure hydrocephalus, SAH: Subarachnoid hemorrhage
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placement to first shunt failure between the different 
types of brain tumor (P = 0.062, log‑rank test) and the 
different locations of brain tumor (P = 0.378, log‑rank 
test) failed to reach statistical significance. Past medical 
history of the patient did not significantly affect the 
median time of shunt survival.
Patients who had a GCS score of less than 13 were 
found to experience early shunt failure (P = 0.010, 
log‑rank test) as shown in Figure 4. Similarly, drowsiness 
or altered consciousness on presentation was found to 
have a significant effect on shunt survival (P = 0.010, 
log‑rank test). This adverse impact of drowsiness or 
altered consciousness on the medial shunt failure time 
was independent of the etiology of hydrocephalus. 
Median shunt survival time was found to be significantly 
different between patients who underwent different types 
of surgical interventions other than VP shunt (P = 0.044, 
log‑rank test). Similarly, median shunt survival time was 
also found to be significantly affected by the placement of 
extra‑ventricular drains (P = 0.033, log‑rank test) before 
VP shunt [Figure 5]. Side of shunt (P = 0.882, log‑rank 
test), hospital care units (P = 0.171, log‑rank test), and 
physiotherapy (P = 0.203, log‑rank test) were not found to 
have any significant effect on medial shunt survival time.
DISCUSSION
Despite the fact that CSF diversion with VP shunt 
placement has been the mainstay of management in both 
pediatric and adult hydrocephalus, VP shunts still have 
noteworthy complications and failure rate.[8,19] The periodic 
evaluation of patients who are managed with VP shunt 
placement for hydrocephalus cannot be overlooked. By 
studying the patterns of shunt survival extensively, one can 
attempt to predict the behavior of VP shunt functioning 
from the time of placement to subsequent follow‑up.
Demographics, such as age, gender, and co‑morbid 
conditions, did not upset the shunt function overall, but 
median time to shunt malfunction was severely affected 
by extreme of age. This might be accounted for by the 
fact that elderly patients have fragile and atrophic brain 
parenchyma. Surgical intervention in such patients 
was probably associated with a higher risk of iatrogenic 
trauma inflicted to the nearby tissues while placing the 
VP shunt. Injury to cells of the choroid plexus within 
the ventricles could lead to the accumulation of cellular 
debris within the catheter and clog the tubing of the 
VP shunt, resulting in shunt blockage.[32] Although this 
explanation seems plausible theoretically, it cannot be 
said with certainty that this was the actual reason for 
early shunt failure in elderly patients in our cohort. 
Another peculiar observation of our study was a slight 
predominance of male patients (66.5%) as opposed to 
female patients (33.5%), which is in line with earlier 
reports from our region.[13,23,35,36] This might be a 
consequence of the male‑dominated structure of the 
local society, cultural traditions, and the type of activities 
that men are more likely to engage into than women.[23]
Among the etiologies of hydrocephalus, hemorrhage 
was found to have a significantly adverse impact on the 
functional outcome of patients, which is in line with 
observation from earlier studies.[3,7,37] VP shunts in patients 
who have experienced intra‑cerebral or intra‑parenchymal 
hemorrhage may become clogged with red blood cells 
and platelet microthrombi, resulting in shunt blockage.[11] 
Similarly, some of the etiologies including intracranial 
hemorrhage, brain tumor, post‑cranial surgery, and NPH 
were found to have the shortest time to first malfunction. 
Development of hydrocephalus following cranial surgery 
may be attributed to the damage that occurred to cells 
Figure 4: Kaplan–Meier shunt survival analysis for adult hydrocephalus 
shows that patients with a GCS score of less than 13 were more 
likely to experience early shunt failure (P = 0.010, log-rank test)
Figure 5: Kaplan–Meier shunt survival analysis for adult hydrocephalus 
shows that median time to first shunt failure was significantly 
different among patients who underwent extra-ventricular drain 
and those who did not (P = 0.033, log-rank test). EVD: Extra-
ventricular drain
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of the choroid plexus and other nearby tissues during 
the surgical procedure.[11,26,39] Therefore, theoretically 
speaking, the indication for which cranial surgery was 
performed, expertise of the operating surgeon, surgical 
techniques employed, as well as other patient factors 
may also influence the survival of VP shunts inserted in 
such patients.[15,20] Likewise, extensive manipulation and 
injury to tissues occurring during resection of neoplastic 
disease, as well as alterations in cerebral blood flow and 
auto‑regulation that occur after the procedure result in 
early shunt failure in patients with brain tumors.[31]
In contrast to the etiology of hydrocephalus, the type 
of hydrocephalus did not influence overall shunt 
malfunction and survival. Albeit previous studies have 
not found any association between clinical features and 
shunt survival,[30] we observed in our study that patients 
with drowsiness and low GCS score on examination had 
prominently reduced median time to first shunt failure. 
GCS score is an indirect measure of brain functionality 
and is often used as a marker of severity of TBI.[41] 
Patients who had a low GCS score on presentation were 
more likely to have severe abnormalities and pathologies 
and, therefore, were at increased risk of experiencing 
shunt failure. However, this association between GCS 
score and early shunt failure has not been previously 
reported. Patients who underwent surgical procedures 
other than VP shunt placement, particularly craniectomy 
for excision and extra‑ventricular drain placement, had a 
decreased median time to first shunt failure. This may 
in turn be related to the induction of inflammation and 
resultant tissue reaction, resulting in precipitation of 
hydrocephalus.[11,20]
Most of the shunt failures occurred within 6 months 
post shunt placement, which is compatible with previous 
reports from developed countries.[5,6,17,20,25,27,30,33,42] Shunt 
obstruction, infection, migration, and CSF ascites 
accounted for the most common causes of shunt 
malfunction. The above observation is also in accordance 
with the previously reported shunt complications.[1,12,25,30]
The VP shunt failure rate reported earlier ranged from 
18% to 29% for adult hydrocephalus.[17,20,30,31,42] The overall 
VP shunt failure rate (15.4%) that we report is consistent 
with the shunt failure rate (15.2%) recently recounted 
by Reddy et al.[30] The shunt failure rates at 6 months, 
i.e. 19/227 (8.37%), and at 500 days, i.e. 26/227 (11.45%), 
are well below the previously reported failure rates. In 
another study, Reddy et al. reported 32% incidence of 
shunt revision in adult hydrocephalus patients.[33] The 
lower shunt failure rate observed in our study was indeed 
surprising. Meticulous surgical technique and improved 
asepsis might be considered as factors for this lower 
rate; however, these factors were not standardized and 
assessed properly in this retrospective study. Moreover, 
meticulous surgical technique would also be utilized in 
other centers, most notably that of Reddy et al.[30] A more 
plausible explanation for this observation could be that 
shunt failure typically implies a symptomatic shunt failure 
requiring revision. Patients who might become shunt 
independent later on would continue to be asymptomatic, 
even if their VP shunt was not functioning. Such patients 
would not be separately excluded from this definition, 
and hence, it might have led to an erroneously low failure 
rate. The question that arises here is should a patient 
with a failed shunt, but no hydrocephalus, be categorized 
as a VP shunt failure? Or should we only consider those 
patients who would require a revision to have a failed 
VP shunt? This could be considered a loophole in the 
definition of shunt failure. In this study, we did not have 
information for asymptomatic patients with shunt failure. 
Consequently, we did not consider such patients to have 
shunt failures. As for the low shunt infection rate in our 
study, it is interesting to note that some other studies have 
also documented a markedly low rate recently.[9,14,16,26,29]
This study has certain limitations due to its retrospective 
design. Results of this study could be affected by technical 
factors like different surgeons, and their experience and 
preference of surgical methods. Moreover, only those 
patients were included in this study whose medical 
records were complete and retrievable; this might have 
introduced selection bias. Shunt survival in patients who 
were excluded due to missing records remains unknown. 
Similarly, shunt survival analysis was performed only for 
those who were able to follow‑up regularly. A significant 
proportion of patients who were either excluded due to 
missing data or failed to follow‑up regularly may have 
skewed the results of our study.
Despite the aforementioned shortcomings, this study 
contributes substantially to the scientific pool of 
knowledge. This is the first study from the region to 
gather and analyze very detailed data of adult patients 
with hydrocephalus undergoing VP shunt placement. 
Patients’ past medical and surgical history, etiology 
of hydrocephalus, hospital course, and follow‑up in 
clinics were extensively studied to find the association 
with shunt survival. Although this study reveals a lower 
shunt failure rate and a median shunt survival time that 
concurs with earlier studies, prospective studies focusing 
on periodic evaluation of shunt and functional status 
may shed more light on the predictors of shunt survival 
and long‑term functional outcome.
CONCLUSIONS
Our study showed that patients undergoing surgical 
excision of tumor and patients in whom extra‑ventricular 
drains were placed were more likely to have an early 
shunt failure. Altered consciousness at presentation (GCS 
score of less than 13) was a predictor of decreased shunt 
survival time. Shunt survival was also significantly 
affected by age and duration of hospital stay.
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